Considering the pharmacokinetics of orally consumed cannabinoid-based food products, how should the oral consumption of cannabinoids proceed? |
|
Are there any strategies in which patients with chronic non-cancer pain can find their optimal dosing regimen without consuming high doses of THC? |
|
Are there any state laws that allow patients to use medical cannabis-based products in hospitals and certain healthcare facilities? |
|
Do CB 2 receptors play a role in diabetic neuropathy? |
|
Does hyperglycemia impact expression of CB2 receptors in the glomerulus? |
|
Is chronic marijuana use associated with higher or lower fasting insulin levels? |
|
Do endocannabinoids impact insulin release? |
|
Have human studies evaluated the effects of cannabinoid consumption on cortisol levels? |
|
Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? |
|
What are some of the more common reasons dermatologists recommend cannabinoid-based medicines? |
Only have a minute but want to Learn something every day®? Sign up to receive The Answer of the Day, bringing featured content from our course library right to your inbox each day.
TheAnswerPage Announces Our New CBD in Clinical Care Course
TheAnswerPage was launched in 1998 to provide daily education to healthcare providers in training and in practice.
Jeffrey Sherwood Block, M.D. . is a Board-certified physician anesthesiologist and adjunct Professor at the University of Miami Miller School of Medicine. Additionally, he is a highly awarded horticulturist and certified Master Gardener educator with the University of Florida’s UF/IFAS Extension Program. Dr. Block’s textbook chapter “Endocannabinoid Receptors and Medical Cannabis” (Advanced Therapeutics in Pain Medicine – CRC Press 2020) is a sentinel work on integrated pain management. Block served as the Florida Medical Association’s “Designated Expert on Botanical Medicines” authoring mandated physician education; and in 2014 was appointed by Florida’s Surgeon General to determine the rules for Florida’s first cannabis law. His consultancy’s demonstrated insight and responsible leadership are valued by both allied professionals and new industries seeking knowledge of future uses for Cannabinoid medicines.